GLP-1 drugs could lower risk of lung issues

young Black female doctor performing finger prick test on older Black female patientShare on Pinterest
GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images.
  • Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD) will hit 600 million by 2050.
  • There are certain risk factors for COPD, including obesity and having type 2 diabetes.
  • A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than those taking DPP-4 drugs.

While anyone might develop COPD, there are certain risk factors that may increase a person’s chance of developing this chronic disease, including smoking, age, genetics, long-term exposure to environmental hazards like air pollution and dust, as well as certain…

Source link

Leave a Comment